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Altered expression of the tetraspanin CD151 is associated with skin tumorigenesis; however, whether CD151 is
causally involved in the tumorigenic process is not known. To evaluate its role in tumor formation, we subjected
epidermis-specific Cd151 knockout mice to chemical skin carcinogenesis. Mice lacking epidermal Cd151
developed fewer and smaller tumors than wild-type mice after treatment with 7,12-dimethylbenzanthracene
(DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA). Furthermore, Cd151-null epidermis showed a reduced
hyperproliferative response to short-term treatment with TPA as compared with wild-type skin, whereas
epidermal turnover was increased. Tumors were formed in equal numbers after DMBA-only treatment. We
suggest that DMBA-initiated keratinocytes lacking Cd151 leave their niches in the epidermis and hair follicles in
response to TPA treatment and subsequently are lost by differentiation. Because genetic ablation of Itga3 also
reduced skin tumor formation, we tested whether reduced expression of a3 could further suppress tumor
formation in epidermis-specific Cd151 knockout mice. Although DMBA/TPA-induced formation of skin tumors
was similar in compound heterozygotes for Cd151 and Itga3 to that in wild-type mice, heterozygosity for Itga3 on
a Cd151-null background diminished tumorigenesis, suggesting genetic interaction between the two genes. We
thus identify CD151 as a critical factor in TPA-dependent skin carcinogenesis.
Journal of Investigative Dermatology (2014) 134, 221–228; doi:10.1038/jid.2013.280; published online 18 July 2013
INTRODUCTION
The tetraspanin CD151 is highly expressed in a variety of cell
types in which it primarily associates with the laminin-binding
integrins a3b1 and a6b4 (Sincock et al., 1997; Kazarov et al.,
2002; Sterk et al., 2002). Patients carrying a nonsense
mutation in CD151 display skin blistering of the pretibia and
kidney dysfunction, defects that are partially recapitulated
in patients with mutations in ITGA3, ITGA6, and ITGB4
encoding the integrin subunits a3, a6, and b4, respectively
(Vidal et al., 1995; Ruzzi et al., 1997; Karamatic-Crew et al.,
2004; Has et al., 2012; Nicolaou et al., 2012). Mice carrying
null mutations for the corresponding genes show phenotypes
similar to those of human patients (Georges-Labouesse et al.,
1996; Kreidberg et al., 1996; van der Neut et al., 1996; Wright
et al., 2004; Sachs et al., 2006).
Although being a component of hemidesmosomes (stable
adhesion plaques anchoring basal keratinocytes to the under-
lying basement membrane) (Sterk et al., 2000), the absence
of CD151 does not cause the severe form of epidermolysis
bullosa observed when the hemidesmosomal integrin a6b4
is deleted. Instead, the mild skin blistering phenotype
resembles that of mice with an epidermis-specific deletion
of Itga3, which develop minor skin defects soon after birth
(Dipersio et al., 1997; Margadant et al., 2009; Has et al.,
2012). Furthermore, a role of CD151 and a3b1 has been
suggested in cell migration during wound healing (Wright
et al., 2004; Cowin et al., 2006; Geary et al., 2008; Reynolds
et al., 2008; Margadant et al., 2009). Finally, both proteins
are involved in skin tumorigenesis: loss of a3b1 decreases
skin tumor formation, whereas it increases progression of
squamous cell carcinomas (SCCs) (Sachs et al., 2012b), and
expression of CD151 in oral SCCs correlates with a decreased
disease-free survival of patients (Romanska et al., 2012).
Expression of a3b1 in the suprabasal epidermis suppresses
malignant conversion (Owens and Watt, 2001), whereas
increased expression of CD151 in SCCs in humans is
correlated with tumor aggressiveness (Suzuki et al., 2011;
Li et al., 2012).
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While this work was in progress, Li et al. (2012) published a
study in which they used Cd151 knockout mice to evaluate
the role of CD151 in mouse skin carcinogenesis. Their results
indicate that CD151 contributes to skin carcinogenesis by
reducing apoptosis in 7,12-dimethylbenzanthracene (DMBA)–
initiated cells and stimulating proliferation of keratinocytes
in response to 12-O-tetradecanoylphorbol-13-acetate (TPA)
treatment. However, because in this study total Cd151
knockout mice were used, Cd151 deletion in tissues other
than epidermis may have influenced the development and
progression of tumors. Furthermore, it was suggested that
CD151 controls keratinocyte proliferation, survival, and
tumorigenesis through the activation of signaling pathways
downstream of the integrin a6b4 (Li et al., 2012). A similar
mechanism has been proposed to explain why CD151
increases mammary tumorigenesis (Deng et al., 2012). How-
ever, CD151 binds most strongly to the integrin a3b1 (Yauch
et al., 1998). We recently showed that epidermal expression of
a3b1 is essential for chemically induced skin carcinogenesis
by retaining slow-cycling cells in their epidermal niches,
allowing them to accumulate a sufficient number of muta-
tions for inducing tumorigenesis (Sachs et al., 2012b). We
wondered whether epidermal expression of CD151 influences
this process through a similar mechanism. We therefore
subjected epidermis-specific Cd151 knockout mice to
chemically induced skin carcinogenesis and tested whether
there is a genetic interaction between Cd151 and Itga3.
RESULTS
Reduced two-stage skin carcinogenesis in the absence of
epidermal Cd151
We first subjected epidermis-specific Cd151 knockout mice
(Cd151fl/fl; K14-Creþ (FVB), referred to as Cd151 eKO) and
wild-type littermates (Cd151fl/fl; K14-Cre- (FVB), referred to as
wild-type) to the two-stage protocol of skin carcinogenesis.
Tumors were initiated with a single dose of DMBA and
promoted with TPA twice per week (Abel et al., 2009). The
average tumor volume was considerably lower in Cd151 eKO
than in wild-type mice, with the average number of tumors
also being slightly lower (Figure 1a and b). Large tumors
appeared later and less frequently in Cd151 eKO mice
(Figure 1c). Apart from their size, we observed no obvious
differences in the histological structure of benign and malig-
nant tumors (Figure 1d). As the deletion of Itga3 in the
epidermis also decreases tumorigenesis (Sachs et al., 2012b),
and CD151 forms a stable complex with a3b1 (Yauch et al.,
1998), we wondered whether the complex is essential for the
effects described above. We therefore decided to investigate
whether there is a genetic interaction between Cd151 and
Itga3 and subjected compound heterozygote mice (Cd151fl/þ ;
Itga3fl/þ ; K14-Creþ , referred to as Cd151 eHET; Itga3 eHET)
to DMBA/TPA-induced tumorigenesis. No differences were
found between Cd151 eHET; Itga3 eHET and wild-type
mice (Cd151þ /þ ; Itga3þ /þ ; K14-Creþ ) with respect to
the number and volume of tumors (Supplementary
Figure S1 online). However, we detected an additional effect
of Itga3 heterozygosity in the complete absence of Cd151
(Cd151fl/fl; Itga3fl/þ ; K14-Creþ , referred to as Cd151 eKO;
Itga3 eHET). Reduced tumor volume (after 18 weeks of tumor
promotion) and number (after 10 weeks of tumor promotion)
compared with Cd151 eKO mice indicated a genetic inter-
action under these circumstances (Figure 1b).
Impaired proliferation of transformed keratinocytes in the
absence of Cd151
To explain the difference in volume of the tumors in wild-type
and Cd151 eKO mice, we examined the proliferative capacity
of epidermal cells in these mice. We therefore treated their
back skin with either single doses of TPA, a single dose of
DMBA followed by four doses of TPA, or respective vehicle
controls. As shown in Figure 2a these short-term treatments
caused epidermal thickening, likely because of increased
proliferation. However, the epidermis of Cd151 eKO mice
was significantly thinner because of a lower proliferation rate
(Figure 2a). It was unlikely that DMBA-induced apoptosis
contributed to this effect as very few interfollicular epidermis
cells died 24 hours after a single DMBA dose, and differences
in the thickness of the epidermis between wild-type and
Cd151 eKO mice were not significant (Figure 2b). TPA-
induced apoptosis seems negligible and was the same in
wild-type and Cd151 eKO mice (Supplementary Figure S2
online). Papillomas originating from DMBA/TPA-treated
Cd151 eKO mice showed significantly less Ki67 labeling than
those in their respective wild-type littermates (Figure 2c).
Furthermore, the proliferative rate of papillomas produced
by Cd151 eKO; Itga3 eHET mice was even further decreased,
indicating genetic interaction (Figure 2c). We next generated
mouse keratinocytes (MKs) from a newborn Cd151fl/fl mouse,
deleted Cd151, rescued expression with either CD151WT or
CD151QRD* (the latter being incapable of binding a3b1;
Kazarov et al., 2002) (Supplementary Figure S3 online), and
determined their proliferative rates. Figure 2d shows that
CD151, but not its integrin-binding function, is required for
efficient proliferation of untransformed keratinocytes in vitro.
Label-retaining cells lacking CD151 exit their niche possibly
because of increased migration
Long-lived, slow-cycling label-retaining cells (LRCs) in hair
follicles (HFs) and the interfollicular epidermis are thought to
be the primary source of chemically induced skin tumors
(Morris et al., 1986). DMBA-initiated cells persist and can be
efficiently promoted to tumors even after extended periods
of time (Berenblum and Shubik, 1949; Stenback et al., 1981).
Furthermore, HFs of adult Itga3 eKO mice contain fewer LRCs
than wild-type ones (Sachs et al., 2012b). We therefore
quantified the number of LRCs in the HFs of Cd151 eKO
mice and wild-type littermates 8 weeks after 6 BrdU pulses
given between 5 and 7 days after birth. As expected, Cd151
eKO HFs contained significantly fewer BrdU-positive LRCs
than wild-type HFs (Figure 3a). In addition, the HF bulge
marker keratin 15 was not limited to HF keratinocytes (wild-
type situation), but was expressed in many keratinocytes in the
infundibulum and the interfollicular epidermis of Cd151 eKO
mice (Figure 3b). To test whether these observations are
correlated with an increased epidermal turnover, we fluores-
cently labeled the cornified layer of wild-type and Cd151 eKO
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mice with dansyl chloride and quantified the remaining
fluorescence after 4 days of daily treatments with TPA.
Interestingly, the rate of dansyl chloride clearance was
almost twice as fast in Cd151 eKO mice as in wild-type
mice (Figure 3c). Furthermore, short-term TPA exposure
leads to a significant increase in keratin 15–positive keratino-
cytes in the suprabasal layer of the Cd151-null epidermis
(Figure 3d).
Loss of Cd151 mildly decreases tumor progression
To investigate whether the observed tumor phenotype was
dependent on the action of TPA, we subjected wild-type and
Cd151 eKO (FVB) mice to the complete carcinogenesis
protocol of weekly DMBA applications. Under these condi-
tions, both mouse strains developed a similar number of
SCCs (Figure 4a and b). Furthermore, histological analysis
showed that the grades of differentiation of SCCs in Cd151
eKO and wild-type mice were similar, although there was
a slight tendency of SCCs to be more poorly differentiated in
wild-type mice (Figure 4c and d and Supplementary Figure S4
online).
In summary, our findings indicate a strong requirement
for CD151 in skin tumor initiation and growth, whereas its
influence on SCC differentiation status is weak.
DISCUSSION
In this study we subjected mice lacking Cd151 in the
epidermis to chemically induced skin carcinogenesis and we
show that efficient tumor formation and growth depends on
epidermal expression of this tetraspanin. Consistent with a
recent report (Li et al., 2012), we found that Cd151 eKO mice
are less susceptible to two-stage skin carcinogenesis as shown
by the number and size of the tumors formed. Especially,
the development of large tumors after DMBA/TPA treatment
depends on CD151. Importantly, tumor growth is dependent
on a sufficient blood supply through angiogenesis (Folkman,
1974), which might be directly affected in total Cd151
knockout mice (Wright et al., 2004; Takeda et al., 2007;
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Figure 1. Impaired tumor formation in Cd151 eKO mice after 7,12-dimethylbenzanthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)
carcinogenesis. (a) Tumor burden of wild-type and Cd151 eKO littermates 20 weeks into the DMBA/TPA protocol. (b) Tumor volume and number are
diminished in Cd151 eKO mice compared with those in wild-type littermates after DMBA/TPA-induced skin carcinogenesis. Both parameters are further reduced
in the absence of one Itga3 allele (* on top of the wild-type group represents Po0.05 compared with Cd151 eKO; Itga3 eHET group; * below the wild-type
group represents Po0.05 compared with Cd151 eKO group as determined by one-way analysis of variance (ANOVA) and Bonferroni). (c) The incidence of
tumors with a diameter of at least 1 mm is equal in the two groups. However, tumors 44 mm occur less often and considerably later in Cd151 eKO mice
than in wild-type littermates. (d) Papillomas and keratoacanthomas of wild-type and Cd151 eKO mice differ in size but not in structure. Moderately differentiated
squamous cell carcinomas (SCCs) are regularly found in both groups (scale bars¼ 100mm).
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Zhang et al., 2011). By using Cd151 eKO mice, we circum-
vented possible indirect effects of the Cd151-deficient
vasculature on skin tumorigenesis.
In agreement with the smaller size of papillomas in Cd151
eKO mice, we observed that the numbers of Ki67þ nuclei in
these mice are decreased, indicative of an impaired prolif-
erative capacity. CD151 has indeed been shown to increase
the proliferation of (transformed) cells by enhancing several
signaling pathways including those activated by EGF, trans-
forming growth factor-b, and hepatocyte growth factor
(Franco et al., 2010; Sadej et al., 2010; Li et al., 2012). In line
with the proposed role of CD151 in modulating the function
of the integrin a3b1 (Nishiuchi et al., 2005), we observed
a similar phenotype in Itga3 eKO mice (Sachs et al., 2012b).
To prove shared functionality of the two proteins, we
generated compound heterozygotes and subjected them to
the two-stage carcinogenesis protocol. However, tumori-
genesis is as efficient in these mice as in wild-type litter-
mates and single heterozygotes. Apparently, a reduction of
the two proteins by 50% is not enough to impair skin
carcinogenesis, possibly because of the still effective form-
ation of functional a3b1–CD151 complexes (Yauch et al.,
1998). However, deletion of one Itga3 allele in Cd151 eKO
mice shows that there is genetic interaction between Itga3
and Cd151 with respect to tumor size and proliferation in
transformed keratinocytes. In contrast to the expression of
a3b1, expression of CD151 in epidermal keratinocytes renders
these cells responsive to TPA-induced proliferation. Consistent
with this observation, CD151 confers a proliferative advantage
over untransformed keratinocytes in vitro also when not
bound to integrins. Proliferation of untransformed keratino-
cytes therefore is independent of CD151–a3b1 complexes,
whereas for proliferation of transformed keratinocytes both
proteins are needed. These experiments also explain why
normal keratinocytes proliferate equally well with or without
a3b1 (Margadant et al., 2009).
The number of DMBA/TPA-induced tumors is decreased
mildly in the absence of epidermal CD151 as compared
with that in wild-type mice. Loss of Cd151 has recently
been shown to increase apoptosis in response to DMBA
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Figure 2. Decreased proliferation of (transformed) keratinocytes lacking Cd151. (a) Single and multiple doses of 12-O-tetradecanoylphorbol-13-acetate
(TPA) applied to Cd151 eKO back skin result in significantly decreased hyperproliferation compared with that of skin of wild-type littermates. (b) The number
of apoptotic cells in the interfollicular epidermis (IFE) of wild-type and Cd151 eKO mice does not differ significantly after a single dose of 7,12-dimethyl-
benzanthracene (DMBA) as assessed by cleaved caspase-3 stainings. (c) Cd151 eKO papillomas of the DMBA/TPA protocol contain significantly less
proliferating cells than wild-type papillomas, as indicated by Ki67 immunohistochemistry. Cd151 eKO; Itga3 eHET papillomas display an even further reduction
in proliferation (scale bars¼ 100mm, 5 insets). (d) In vitro, untransformed Cd151 / mouse keratinocytes proliferate significantly less strongly than cells
from the parental Cd151fl/fl mouse keratinocyte (MK) line. The proliferation defect is rescued by the expression of not only wild-type, but also the integrin-binding
mutant CD151 (see Supplementary Figure S2 online for characterization of these cells).
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(Li et al., 2012). Even though we failed to reproduce the
statistical significance of these results, we cannot exclude that
fewer DMBA-initiated cells survive in the absence of Cd151.
In fact, we did observe a trend for higher DMBA sensitivity in
the absence of Cd151, similar to that seen in the absence of
a3b1 (Sachs et al., 2012b). Given the very low number of
apoptotic cells following DMBA exposure, we focused on the
fate of slow-cycling LRCs as the proposed cells from which
tumors are formed (Berenblum and Shubik, 1949; Stenback
et al., 1981; Morris et al., 1986). We found a strong asso-
ciation between the decrease in the number of tumors and the
absence of slow-cycling LRCs in the HFs of the Cd151 eKO
mice. Interestingly, a similar association was observed in mice
lacking epidermal a3b1 (Sachs et al., 2012b). Deletion of one
Itga3 allele in Cd151 eKO mice further decreases the number
of tumors. However, epidermal turnover is only increased in
Cd151 eKO mice as compared with that in wild-type mice
following exposure to TPA. Whereas this increased turnover
in Cd151 eKO mice is dependent on the treatment with
TPA, it is not in Itga3 eKO mice (Sachs et al., 2012b). Further-
more, because the proliferation of epidermal keratinocytes
is decreased in Cd151 eKO mice, it is likely that their
differentiation is increased.
Functionally, CD151 forms tight complexes with a3b1
(Yauch et al., 1998) that increase cell adhesion and decrease
cell migration (Chometon et al., 2006; Sachs et al., 2012a).
Deletion of Cd151 delays epidermal re-epithelialization and
keratinocyte migration following skin wounding (Cowin
et al., 2006; Geary et al., 2008) and a mAb against CD151
immobilizes tumor cells in vivo (Zijlstra et al., 2008). In
keratinocytes, the integrin a6b4–based hemidesmosomes
render a3b1–CD151 adhesions less important. Disassembly
of hemidesmosomes through TPA-mediated phosphorylation
of b4 causes decreased keratinocyte adhesion and increased
migration (Frijns et al., 2010). The simultaneous weakening
of two main keratinocyte adhesion structures (TPA treatment
increases hemidesmosome dynamics, whereas deletion of
Cd151 weakens a3b1-mediated cell adhesion) may thus
result in a similar phenotype as produced by deletion of
Itga3, namely increased epidermal turnover and fewer
tumors. The TPA dependence of suppressing tumorigenesis in
the Cd151 eKO mice is apparent in the DMBA-only model of
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Figure 3. Loss of label-retaining cells (LRCs) lacking Cd151. (a) The number of BrdU LRCs is significantly reduced in the back skin hair follicles (HFs) of
8-week-old Cd151 eKO mice compared with HFs of wild-type littermates. (b) Krt15þ keratinocytes are confined to the HFs of wild-type mouse tails, but present in
HFs and interfollicular epidermis (IFE) of Cd151 eKO mouse tails (dotted lines outline HF; scale bars¼100mm). DP, dermal papilla; Inf., infundibulum;
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Cd151 eKO back skin is shown by accelerated loss of dansyl chloride from the epidermis after 4 days of daily TPA treatments. (d) Krt15þ keratinocytes are
restricted to the basal IFE of Cd151 eKO mouse tails (bottom row), but regularly found suprabasally after 2 days of daily TPA applications (top row). Displayed are
XY projections (large image) as well as XZ and YZ projections along the indicated white lines (narrow images below and to the right of XY images). Scale
bars¼ 50mm.
N Sachs et al.
CD151 in Skin Tumorigenesis
www.jidonline.org 225
complete carcinogenesis. In contrast to Itga3 eKO mice (Sachs
et al., 2012b), Cd151 eKO mice develop the same number of
SCCs as wild-type littermates. SCCs lacking CD151 show a
higher degree of differentiation that is consistent with the
strongly positive effect of CD151 on proliferation and its
correlation with SCC aggressiveness in men (Suzuki et al.,
2011). Together, our studies identify CD151 as an essential
factor in chemically induced skin carcinogenesis, and show
that it supports tumorigenesis through mechanisms that are
both dependent and independent of its association with the
integrin a3b1.
MATERIALS AND METHODS
Animal experiments
According to Mouse Genome Informatics (The Jackson Labo-
ratory, Bar Harbor, ME) the names of Itga3 eKO and Cd151 eKO
mice are Itga3tm1Son/tm1Son; Krt14tm1(cre)Wbm on FVB(N6), and
Cd151tm2Son/tm2Son; Krt14tm1(cre)Wbm on FVB(N10), respectively
(Huelsken et al., 2001; Sachs et al., 2006, 2012a). Compound hetero-
zygotes were produced by crossing the mice mentioned above.
For DMBA/TPA-induced carcinogenesis, the backs of 7-week-old
mice were shaved and treated with a single dose of DMBA (30mg in
200ml acetone; Sigma-Aldrich, St Louis, MO) followed by biweekly
applications of TPA (12.34mg in 200ml acetone; Sigma-Aldrich) for
20 weeks. For DMBA-only carcinogenesis, the backs of 7-week-old
mice were shaved and treated with weekly doses of DMBA (30mg in
200ml acetone) for up to 25 weeks. Number and size of arising
tumors were measured weekly. For short-term treatments, mice were
treated with a daily dose of 12.34mg TPA (1 day, Figure 2a; 2 or
4 days, Figure 3c and d) and killed 24 hours later, with a single dose
of 30mg DMBA and killed 24 hours later (Figure 2b), or with a single
dose of 30mg DMBA followed by 4 semiweekly doses of 12.34mg
TPA and killed 3 days later (Figure 2a and Supplementary Figure S2A
online). For LRC tracing, mice were injected intraperitoneally with
6 50mg BrdU every 12 hours from day 3 (Cotsarelis et al., 1990)
and chased for 14 days. We dissected fourB1 cm long skin strips per
mouse and counted BrdUþ and Brdu cells of the bulges of HFs
whose dermal papilla and isthmus were present in the histological
sections (at least 25 per mouse). All animal studies were performed
according to Dutch guidelines for care and use of laboratory animals
and were approved by the animal welfare committee of the
Netherlands Cancer Institute.
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Figure 4. Complete carcinogenesis in wild-type and Cd151 eKO mice. (a) Macroscopic image of two littermates following a 25-week regimen of
7,12-dimethylbenzanthracene (DMBA)-only carcinogenesis with (b) corresponding quantification of the entire cohort. Cd151 eKO and wild-type mice develop
the same number of tumors. (c) Representative histological examples of squamous cell carcinomas (SCCs) found in wild-type and Cd151 eKO mice after
complete carcinogenesis (scale bars¼ 1 mm (overview) and 100mm (detail)). (d) Pie chart of SCC differentiation showing mild increase of poorly differentiated
SCCs in the wild-type group (Po0.0005; w2 test; see Supplementary Figure S4 online for total tumor numbers).
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Histology
Tissues were excised, fixed for 1 day in formaldehyde, embedded in
paraffin, sectioned, and stained with hematoxylin and eosin. Images
were taken with PL APO objectives (10 /0.25 NA, 40 /0.95 NA,
and 63 /1.4 NA oil) on an Axiovert S100/AxioCam HR color system
using AxioVision 4 software (Carl Zeiss MicroImaging, Oberkochen,
Germany) or with a 20 /0.75 NA PL APO objective±a 2 optical
mag changer on a ScanScope XT system using ImageScope v10
software (Aperio Technologies, Vista, CA). Tumor classification and
grading were performed blindly by a mouse pathologist according
to the degree of differentiation of the tumor cells, mitotic activities of
the cells, organization and demarcation of the tumor, necrosis,
hemorrhages, and stromal reaction.
Immunohistochemistry and immunofluorescence
Skin was excised and embedded in cryoprotectant (Tissue-Tek,
optimum cutting temperature, Sakura Finetek, Alphen aan den Rijn,
The Netherlands). Cryosections were prepared, fixed in ice-cold
acetone, and blocked with 2% BSA in phosphate-buffered saline
(PBS). To prepare epidermal whole mounts, tail skin was cut into
0.5 cm wide pieces and incubated in 5 mM EDTA in PBS at 37 1C for
4 hours. An intact sheet of epidermis was gently peeled away from the
dermis and fixed in 4% paraformaldehyde in PBS for 2 hours at room
temperature. Fixed epidermal sheets were permeabilized and blocked
in PB buffer (20 mM HEPES buffer pH 7.2 containing 0.5% Triton
X-100, 0.5% skim milk powder, and 0.25% fish skin gelatin) and
incubated with 2 M HCl at 37 1C for 25 minutes when indicated (anti-
BrdU stainings). Tissues were incubated with the indicated primary
antibodies in 2% BSA in PBS (whole mounts in PB buffer) for
60 minutes (whole mounts o/n), followed by incubation with second-
ary antibodies diluted 1:200 for 60 minutes (o/n). The following
antibodies were used: mouse anti-BrdU mAb (MO744, Dako,
Glostrup, Denmark), mouse anti-human CD151 (11B1.G4) (Ashman
et al., 1997), rabbit anti-cleaved caspase-3 (9661L, Cell Signaling
Technology, Danvers, MA), rabbit anti-mouse CD151 (Sachs et al.,
2006), mouse anti-FLAG (M2; Sigma-Aldrich), rabbit anti-FLAG (Sc-
807; Santa Cruz Biotechnology, Dallas, TX), mouse anti-mouse
integrin-a3 (29A3) (de Melker et al., 1997), rat anti-mouse integrin b4
(346-11A; BD Biosciences, San Jose, CA), mouse anti-mouse Ki67
(PSX1028; Sanbio, Uden, The Netherlands), and mouse anti-mouse
keratin 15 (MA1-90929; Thermo Fisher Scientific, Waltham, MA).
Samples were analyzed at 37 1C using a 63 /1.4 HCX PL APO CS oil
objective on a TCS SP2 AOBS confocal microscope (Leica
Microsystems GmbH, Wetzlar, Germany). Images were acquired
using LCS 2.61 (Leica Microsystems) and processed using Adobe
Photoshop CS4 (Adobe Systems, San Jose, CA) or ImageJ (National
Institutes of Health, Bethesda, MD).
Cell lines
MK Cd151fl/fl were generated from neonatal Cd151tm2Son/tm2Son mice
as described (Margadant et al., 2009) and grown in keratinocyte
serum-free medium (Invitrogen, Carlsbad, CA) supplemented with
50mg ml 1 bovine pituitary extract, 5 ng ml 1 EGF, 100 U ml 1
penicillin, and 100 U ml 1 streptomycin. Adeno-Cre obtained from
F Graham (Anton and Graham, 1995) was used to delete Cd151 and
generate MK Cd151 / . Retroviral expression constructs carrying
wild-type and 194QRD-INF196 CD151 from M Hemler (Kazarov
et al., 2002) were used to rescue expression of CD151 in MK
Cd151 / . Cells were seeded at 5,000 cells per well of a standard
12-well plate and counted daily in duplicate to measure proliferation.
Immunoblotting and immunoprecipitations
For biochemical assays, cells were lysed in 1% (vol/vol) Nonidet
P-40, 20 mM Tris-HCl, pH 7.6, 4 mM EDTA, and 100 mM NaCl,
supplemented with a cocktail of protease inhibitors (P8340;
Sigma-Aldrich). Lysates were cleared by centrifugation for 20 minutes
at 20,000 g and 4 1C, followed by separation of proteins on 4–12%
polyacrylamide gels under nonreducing conditions (NuPage, EMD
Millipore, Billerica, MA), and transferred to Immobilon polyvinylidene
difluoride membranes (EMD Millipore). For immunoprecipitations,
lysates were incubated overnight with mAb 29A3 coupled to
gamma-bind sepharose (GE Healthcare, Little Chalfont, UK) or mAb
M2-coupled agarose (A2220; Sigma-Aldrich). Beads were spun down
at 500 g, washed with lysis buffer and PBS, and processed by
SDS–PAGE, as above. After western blotting, membranes were blocked
and blots were developed with the indicated antibodies using an ECL
detection kit (GE Healthcare) according to the manufacturer’s protocol.
FACS
Cells were trypsinized, washed with 2% fetal calf serum in PBS, and
stained with primary antibodies as indicated for 60 minutes on ice.
Following washing, secondary anti-goat, anti-rat, and anti-mouse
antibodies coupled to FITC were used 1:200 for 60 minutes on ice.
Cells were strained and analyzed on a 1998 BD FACSCalibur
(Becton, Dickinson and Company, Franklin Lakes, NJ) using a
488 nm laser and a 530/30 FL1 filter configuration.
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